Sun Pharma turns ex-dividend July 7 for a Rs 5 final dividend; check record date, AGM and other details.
Sun Pharma, Dr Reddy’s, Zydus and Divi’s Labs turn ex-dividend in July as pharma stocks near highs; check record dates…
Watch Biocon and pharma stocks for a potential Nifty rebound as FIIs cover shorts—stay updated on key breakout levels!
This smallcap company just bought a debt-free, Aramco-approved Saudi pipe maker at 1.5x EBITDA. The asset is not the catch.…
Discover top 10 broker-rated ‘Buy’ stocks this week, with projected returns of 15%-60%. Explore the picks and invest smartly!
Indian companies are buying global businesses at a record pace. From Sun Pharma’s $11.75 billion Organon deal to Tata Motors…
Sun Pharma’s Q4FY26 numbers missed on margins but not on confidence. Three brokerages stayed bullish as specialty medicines, India growth…
Sun Pharma posted strong Q4 profit and revenue growth as its India business gained market share and innovative medicines business…
Corporate India is set for a packed Q4FY26 earnings week with 680 companies announcing results. Key names include ITC, BPCL,…
Vedanta’s demerger unlocks hidden value, with Emkay projecting a 16% upside—discover if the split benefits your portfolio today!
Anupam Mittal calls Sun Pharma Organon deal a wake-up call, urging Indian IT giants to shift from services to IP-driven…
Jefferies bullish on Emmvee Photovoltaic, Bajaj Finance, KFin Tech; sees 26–36% upside on strong earnings growth
Motilal Oswal bullish on Federal Bank, Indian Bank, IIFL Finance, Five Star; sees up to 34% upside amid sector pressure
Markets surged, but not on fresh buying: Ambit sees a short-covering rally as rollover data reveals selective bets in pharma,…
Rupee nears 95 per US dollar amid oil price surge, pharma outflow, and weak IIP; know the outlook for currency.
India and New Zealand have signed a Free Trade Agreement set to be operational by year-end, offering duty-free access for…
Goldman Sachs sees 22% upside for Paytm stock despite PPBL setback; explore why experts remain bullish!
Sun Pharma’s mega deal sparks a rally, but Paytm’s RBI shock and Axis Bank’s earnings drag sentiment. Here’s what’s really…